KUCHARCHUK ANDREW ALBERT
Transactions
10
Companies
6
Filings
9
CIK
0001654127
Recent Transactions
- Award
Stock Option (Right to Buy)
2026-01-07+1,162,099→ 1,162,099 total - Award
- Award
- Award
- Award
- Award
- Award
Employee Stock Option (right to buy)
2018-05-09+3,000,000→ 3,000,000 total - Award
Emplyee Stock Option (right to buy)
2017-03-10+2,000,000→ 2,000,000 total - Award
Employee Stock Option (right to buy)
2017-03-10+2,000,000→ 2,000,000 total - Award
Companies
6- $ATRX
Adhera Therapeutics, Inc.
Director, Chief Executive Officer
- $CERO
CERO THERAPEUTICS HOLDINGS, INC.
Chief Financial Officer
- $CBGGF
Chain Bridge I
Chief Financial Officer
- $RNGT
Range Capital Acquisition Corp II
Chief Financial Officer
- $THER
THERALINK TECHNOLOGIES, INC.
Director, CFO & President
- $WINT
WINDTREE THERAPEUTICS INC /DE/
Director
Recent Filings
9- 4
KUCHARCHUK ANDREW ALBERT
Jan 9, 2026
- 4
KUCHARCHUK ANDREW ALBERT
Jun 2, 2025
- 4
KUCHARCHUK ANDREW ALBERT
Oct 2, 2024
- 4
KUCHARCHUK ANDREW ALBERT
Jun 9, 2020
- 4
KUCHARCHUK ANDREW ALBERT
May 8, 2020
- 4/A
KUCHARCHUK ANDREW ALBERT
Mar 14, 2019
- 4
KUCHARCHUK ANDREW ALBERT
May 11, 2018
- 4
OncBioMune Pharmaceuticals, Inc
Apr 20, 2017
- 4
OncBioMune Pharmaceuticals, Inc
Feb 4, 2016
Address
CERO THERAPEUTICS HOLDINGS, INC. 201 HASKINS WAY, SUITE 230
SOUTH SAN FRANCISCO, CA, 94080